 reduct glomerular hyperfiltr normoalbuminur iddm patient mo aldos reductas inhibit hyperglycemia glucos metabol polyol pathway tissu insulin glucos uptak high level aldos reductas activ function structur abnorm diabet develop late complic effect aldos reductas inhibitor ponalrestat kidney function uncompl insulin-depend diabet iddm normoalbuminur iddm patient mo treatment ponalrestat mean SD age yr durat yr mo placebo age yr durat yr glomerular filtrat rate clearanc iothalam ponalrestat-tr patient chang placebo renal plasma flow clearanc hippuran urinari albumin excret rate radioimmunoassay fraction albumin clearanc renal vascular resist unchang group modest increas ponalrestat unchang placebo side effect ponalrestat inhibit aldos reductas characterist hyperfiltr uncompl iddm